Perspective Therapeutics Inc. (CATX) — Capital Reinvestment Ratio

Latest as of September 2024: 8.83x

Perspective Therapeutics Inc. (CATX) has a Capital Reinvestment Ratio of 8.83x as of September 2024, meaning it reinvests 9% of its operating cash flow ($3.37 Million) in capital expenditures ($29.71 Million). See how leveraged is Perspective Therapeutics Inc.'s balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

8.83x
Capex / Operating Cash Flow

Operating Cash Flow

$3.37 Million
USD

Capital Expenditures

$29.71 Million
USD

Data as of

Sep 2024
Most recent filing

Perspective Therapeutics Inc. Capital Reinvestment Ratio (1999–2001)

This chart tracks Perspective Therapeutics Inc.'s Capital Reinvestment Ratio across 4 annual periods. Check total reinvestment intensity of Perspective Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Perspective Therapeutics Inc. (1999–2001)

Year-by-year Capital Reinvestment Ratio for Perspective Therapeutics Inc. from 1999 to 2001. For live market cap and broader valuation context, see market value of Perspective Therapeutics Inc..

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2001 0.13x $365.34K $48.81K ▲ +0.0%
2000 0.13x $365.34K $48.81K ▼ -76.9%
1999 0.58x $275.97K $159.58K ▲ +0.0%
1999 0.58x $275.97K $159.58K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow